Approval · Notice of Compliance 5888 · 1994
QUESTRAN-LIGHT: Notice of Compliance 5888
Issued March 16, 1994
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5888
- Date
- March 16, 1994
- Company
- Bristol Labs Division Of Bristol-Myers SquibbMontreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New packaging
- Therapeutic class
- Antidiarrheal and antihypercholesterolemic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| QUESTRAN-LIGHT | Not yet assigned | — |
Medicinal ingredients
- CHOLESTYRAMINE RESIN 4 G per DOSE